Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Avalon Partnership Adds 2 More Startups

September 26, 2014 – 2:35 pm | Edit Post

Avalon Ventures LLC announced the launch of two biotech companies formed through its collaboration with British drugmaker, GlaxoSmithKline Plc. The partnership will funnel $495 million into 10 new biotech companies by 2016.

Disease Without Borders

September 26, 2014 – 12:12 pm | Edit Post

In a paper published this week online in Global Society, researchers with University of California, San Diego School of Medicine and the Urban Studies and Planning Program, also at UC San Diego, present a bioregional guide that merges place-based (territorial) city planning and ecosystem management along the United States-Mexico border as way to improve human and environmental health.

West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More

September 26, 2014 – 3:30 am | Edit Post

[Updated with Novo Nordisk obesity news, 9/26/14, 12:38pm. See below.] Out west this week, there was Ebola-related pharmaceutical news large and small. Vancouver biotech Tekmira Pharmaceuticals…

[[Click headline to continue reading.]]

UCSD named to autoimmune disease project

September 25, 2014 – 8:03 pm | Edit Post

UC San Diego has been named to a $41.6 million autoimmune disease program.

UC San Diego Part of New Effort to Fight Autoimmune Disorders

September 25, 2014 – 1:53 pm | Edit Post

The Division of Rheumatology, Allergy and Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus, which affect millions of Americans.

UC San Diego Health System Continues to Provide Exceptional Care by “Top Docs”

September 25, 2014 – 11:29 am | Edit Post

More than 100 physicians from UC San Diego Health System were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 40 diverse specialties, from internal medicine and oncology to obstetrics, cardiovascular and surgical care.

Modified vitamin D shows promise as treatment for pancreatic cancer

September 24, 2014 – 5:00 pm | Edit Post

LA JOLLA–A synthetic derivative of vitamin D was found by Salk Institute researchers to collapse the barrier of cells shielding pancreatic tumors, making this seemingly impenetrable cancer much more susceptible to therapeutic drugs.

Backed By a Baidu Founder, Allele Raises $7M to Reprogram Stem Cells

September 24, 2014 – 9:09 am | Edit Post

After subsisting mostly on Small Business Innovation Research grants and sales of laboratory reagents over the past 15 years, San Diego-based Allele Biotechnology & Pharmaceuticals says it has…
[[Click headline to continue reading.]]

Scripps to make artificial immune system

September 24, 2014 – 7:45 am | Edit Post

Scripps Research scientists to make an artificial immune system under a $7.9 million grant.

Avelas Biosciences completes $7.4M funding

September 23, 2014 – 4:50 pm | Edit Post

Cancer diagnostics developer Avelas Biosciences has raised $7.4 million.